Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Syngene International Ltd

NSE: SYNGENE · BSE: 539268 · Pharmaceuticals & Biotechnology · 38 announcements

Share price
₹360.30
Market cap
₹14,544 Cr
Revenue (annual)
₹3,739 Cr
Net profit (annual)
₹316.7 Cr
P/E (TTM)
65.8×Sector 47.3×
Promoter holding
52.59%-0.09% QoQ
FII holding
11.82%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

22:50 IST NSE
Management Change

Syngene International Management Change

Syngene International Limited announced the resignation of Mr. Pramuch Goel, Head of Corporate Affairs & Communications and Senior Management Personnel, effective September 21, 2026.

20:01 IST NSE
Management Change

Syngene International Management Change

Independent Director Mr. Kush Parmar resigned from Syngene International, effective July 29, 2026, due to overseas commitments. He also vacated his board committee memberships.

17:48 IST NSE
Management Change

Syngene International Management Change

Syngene International announced that General Counsel Surender Sharma will leave the company on July 15, 2026. He resigns by mutual consent to pursue other career opportunities.

17:34 IST NSE
Management Change

Syngene International Management Change

Siddharth Mittal has been appointed as Managing Director and CEO of Syngene International. He succeeds Peter Bains effective July 1, 2026.

20:35 IST NSE
Management Change

Syngene International Management Change

Syngene International Limited has appointed M/s. S. R. Batliboi & Associates LLP as its Statutory Auditor for a five-year term (60 months) effective July 29, 2026. The appointment was approved during a board meeting on April 29, 2026.

Execution
60 months
18:54 IST BSE
Management Change

Syngene International Management Change

Syngene International approved the appointment of Mr. Vijaya Chandru and Mr. Arun Chandavarkar as Independent Directors for three-year terms starting July 2026. Additionally, Ms. Vinita Bali was reappointed as a Non-Executive Director for one year. These leadership updates, subject to shareholder approval, aim to strengthen the board's strategic oversight and governance.

Execution
3 years for new directors; 1 year for reappointed director